MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 94 filers reported holding MERUS N V in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,072,000 | -33.7% | 253,200 | -25.1% | 2.10% | -39.3% |
| Q2 2022 | $7,652,000 | -14.4% | 338,000 | 0.0% | 3.45% | +24.3% |
| Q1 2022 | $8,937,000 | -11.6% | 338,000 | +6.4% | 2.78% | +29.5% |
| Q4 2021 | $10,106,000 | +358.1% | 317,800 | +217.0% | 2.14% | +420.1% |
| Q3 2021 | $2,206,000 | -64.4% | 100,250 | -71.6% | 0.41% | -49.0% |
| Q4 2020 | $6,188,000 | +309300.0% | 353,000 | +176400.0% | 0.81% | – |
| Q3 2020 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |